Intuitive Surgical, Inc. (NASDAQ:ISRG) executive Robert DeSantis, the company's EVP & Chief Strategy & Corporate Operations, has recently engaged in multiple transactions involving the company's common stock, according to a new SEC filing. On May 10th and 13th, DeSantis sold a total of 523 shares at prices ranging from $385.55 to $389.16, generating over $202,667 in proceeds.
In addition to the sales, DeSantis also acquired shares through option exercises on the same dates. The executive exercised options to purchase 329 shares of common stock at prices between $179.7 and $304.67, amounting to a total of $80,030. These transactions were part of a prearranged Trading Plan that complies with SEC Rule 10b5-1, which allows insiders to set up a trading schedule in advance to avoid any accusations of trading on nonpublic information.
Furthermore, DeSantis also engaged in transactions involving derivative securities. These included the exercise of options for zero dollars, which did not contribute to the total transaction value. However, a transaction coded as "F" for tax withholding purposes involved the disposition of 167 shares at a price of $386.7, totaling $64,578.
The recent transactions by DeSantis offer a glimpse into the trading activities of high-level executives within Intuitive Surgical. Such filings provide transparency and can serve as a point of interest for investors tracking insider behaviors at major corporations.
InvestingPro Insights
Intuitive Surgical's executive Robert DeSantis's recent stock transactions come at a time when the company's financial health and market performance are of keen interest to investors. According to real-time data from InvestingPro, Intuitive Surgical (NASDAQ:ISRG) boasts a robust market capitalization of $136.27 billion USD and has experienced a revenue growth of 13.81% over the last twelve months as of Q1 2024. This indicates a strong top-line performance for the company in a competitive medical technology market.
The company's P/E ratio stands at 67.86, and it's adjusted slightly higher to 68.23 for the last twelve months as of Q1 2024, which may suggest that the stock is trading at a premium compared to its earnings. This aligns with one of the InvestingPro Tips, which notes that ISRG is trading at a high earnings multiple. Additionally, Intuitive Surgical's Price / Book ratio is at 9.76 for the same period, another metric indicating a high valuation by the market, especially in relation to the company's book value.
Investors should also note that while Intuitive Surgical is trading at a high valuation multiple, the company's stock has exhibited low price volatility, as per another InvestingPro Tip. This could be an important factor for those looking for stable investments in the healthcare technology sector. For those interested in deeper analysis, there are over 13 additional InvestingPro Tips available, which can be explored for a more comprehensive understanding of Intuitive Surgical's financial health and market position. To access these tips and metrics, visit: https://www.investing.com/pro/ISRG.
For investors who find these insights valuable and wish to delve further into Intuitive Surgical's financials and market performance, InvestingPro offers a wealth of additional tips and data. To enhance your research, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.